Akebia Shares Spike Sharply Higher As Traders Get Word Of Earlier $90 Price Target By Morgan Stanley

Shares of Akebia Therapeutics (NASDAQ: AKBA) are seeing a somewhat surprising sharp spike higher Monday afternoon following a CNBC ...